Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nautilus Biotechnology, Inc. | 971,885 | reported | 02 Jun 2026 | tx 2−5,000,000 |
| CM Life Sciences III Inc. | 0 | reported | 09 Nov 2023 | tx 8−59,695,246 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jun 2026 | SALE | Nautilus Biotechnology, Inc. | 4,615,974 | 2.35 USD | |
| 02 Jun 2026 | SALE | Nautilus Biotechnology, Inc. | 384,026 | 2.35 USD | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 5,000,000 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 11,433,677 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 17,438,465 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 12,264 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 19,192,015 | — | |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 2,401,418 | — | deriv |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 2,642,897 | — | deriv |
| 09 Nov 2023 | TENDER | CM Life Sciences III Inc. | 1,574,510 | — | deriv |